Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro‐oesophageal reflux disease: a matched case–control study
- 23 July 2008
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 28 (4) , 491-496
Abstract
Gastrin and pepsinogens reflect the functional state of the gastric mucosa. To evaluate whether serum gastrin and pepsinogens correlate with the different grades of severity of gastro-oesophageal reflux disease (GERD). In all, 388 patients with heartburn not taking any form of acid suppressive therapy were matched-controlled for age and gender and sub-classified into four groups: group 1 non-erosive reflux disease (NERD); group 2, erosive reflux disease (ERD) Los Angeles (LA) A and B, group 3, ERD LA C and D; group 4 Barrett's oesophagus (BO). Fasting serum was analysed for gastrin 17, pepsinogen I, pepsinogen II und Helicobacter pylori using specific EIA tests (GastroPanel; Biohit, Plc). Kruskal-Wallis test and analysis of variance. There was a significant difference among the four groups with respect for pepsinogen I, but not for pepsinogen II, the pepsinogen I pepsinogen II ratio, H. pylori serology and gastrin levels. Pepsinogen I was the lowest in NERD and the highest in BO (median 91.6, mean +/- standard deviation 106.2 +/- 51.6 vs. median 114.7, mean +/- standard deviation 130.4 +/- 70.6; P = 0.046). Pepsinogen I levels were higher in H. pylori positive subjects. After adjusting for H. pylori status, the differences in pepsinogen I across patient groups were no longer statistically significant (P = 0.298). Serum gastrin and pepsinogen I and II do not correlate with the different grades of severity of GERD. The non-invasive GastroPanel is not useful for the differentiation of the various forms of GERD.Keywords
This publication has 33 references indexed in Scilit:
- Prospective Follow-Up Data from the ProGERD Study Suggest that GERD Is Not a Categorial DiseaseAmerican Journal of Gastroenterology, 2006
- The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based ConsensusAmerican Journal of Gastroenterology, 2006
- Biomarkers in Patients with Gastric Inflammation: A Systematic ReviewDigestion, 2005
- Gastro esophageal reflux disease is associated with absence from work: Results from a prospective cohort studyWorld Journal of Gastroenterology, 2005
- Low circulating levels of gastrin-17 in patients with Barrett's esophagusWorld Journal of Gastroenterology, 2005
- Atrophic Gastritis Serum Levels of Amidated Gastrin-17 and Pepsinogen I in Atrophic Gastritis: An Observational Case-Control StudyScandinavian Journal of Gastroenterology, 2002
- The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer ratesGastroenterology, 1994
- Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagusDigestive Diseases and Sciences, 1992
- Elevated gastric acid secretion in patients with Barrett's metaplastic epitheliumDigestive Diseases and Sciences, 1989
- Bombesin and G-17 dose responses in duodenal ulcer and controlsDigestive Diseases and Sciences, 1985